137 related articles for article (PubMed ID: 15138382)
1. Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures.
Chondrogianni N; Gonos ES
Biogerontology; 2004; 5(1):55-61. PubMed ID: 15138382
[TBL] [Abstract][Full Text] [Related]
2. Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation.
Chondrogianni N; Stratford FL; Trougakos IP; Friguet B; Rivett AJ; Gonos ES
J Biol Chem; 2003 Jul; 278(30):28026-37. PubMed ID: 12736271
[TBL] [Abstract][Full Text] [Related]
3. Cellular senescence in human keratinocytes: unchanged proteolytic capacity and increased protein load.
Brégégère F; Soroka Y; Bismuth J; Friguet B; Milner Y
Exp Gerontol; 2003 Jun; 38(6):619-29. PubMed ID: 12814797
[TBL] [Abstract][Full Text] [Related]
4. Metabolic stabilization of MAP kinase phosphatase-2 in senescence of human fibroblasts.
Torres C; Francis MK; Lorenzini A; Tresini M; Cristofalo VJ
Exp Cell Res; 2003 Nov; 290(2):195-206. PubMed ID: 14567979
[TBL] [Abstract][Full Text] [Related]
5. An analysis of replicative senescence in dermal fibroblasts derived from chronic leg wounds predicts that telomerase therapy would fail to reverse their disease-specific cellular and proteolytic phenotype.
Stephens P; Cook H; Hilton J; Jones CJ; Haughton MF; Wyllie FS; Skinner JW; Harding KG; Kipling D; Thomas DW
Exp Cell Res; 2003 Feb; 283(1):22-35. PubMed ID: 12565817
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of proteasome function induced apoptosis in gastric cancer.
Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD
Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889
[TBL] [Abstract][Full Text] [Related]
8. Unexpected transcriptional induction of monocyte chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway.
Nakayama K; Furusu A; Xu Q; Konta T; Kitamura M
J Immunol; 2001 Aug; 167(3):1145-50. PubMed ID: 11466328
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency.
Kim KB; Myung J; Sin N; Crews CM
Bioorg Med Chem Lett; 1999 Dec; 9(23):3335-40. PubMed ID: 10612595
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-proteasome pathway as a new target for the prevention of restenosis.
Meiners S; Laule M; Rother W; Guenther C; Prauka I; Muschick P; Baumann G; Kloetzel PM; Stangl K
Circulation; 2002 Jan; 105(4):483-9. PubMed ID: 11815432
[TBL] [Abstract][Full Text] [Related]
11. Differential susceptibility of normal and PARP knock-out mouse fibroblasts to proteasome inhibitors.
Wesierska-Gadek J; Bohrn E; Herceg Z; Wang ZQ; Wurzer G
J Cell Biochem; 2000 Jun; 78(4):681-96. PubMed ID: 10861865
[TBL] [Abstract][Full Text] [Related]
12. Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates.
Rodgers KJ; Dean RT
Int J Biochem Cell Biol; 2003 May; 35(5):716-27. PubMed ID: 12672463
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
Wagenknecht B; Hermisson M; Eitel K; Weller M
Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibition induces nuclear translocation of the dioxin receptor through an Sp1 and protein kinase C-dependent pathway.
Santiago-Josefat B; Fernandez-Salguero PM
J Mol Biol; 2003 Oct; 333(2):249-60. PubMed ID: 14529614
[TBL] [Abstract][Full Text] [Related]
15. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR
Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
17. Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide.
El-Shami KM; Tirosh B; Popovic D; Carmon L; Tzehoval E; Vadai E; Feldman M; Eisenbach L
Int J Cancer; 2000 Jan; 85(2):236-42. PubMed ID: 10629083
[TBL] [Abstract][Full Text] [Related]
18. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
[TBL] [Abstract][Full Text] [Related]
19. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
[TBL] [Abstract][Full Text] [Related]
20. Heat-shock protein 70 antisense oligomers enhance proteasome inhibitor-induced apoptosis.
Robertson JD; Datta K; Biswal SS; Kehrer JP
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):477-85. PubMed ID: 10567231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
